Stepan Reports Fourth Quarter Results and Record Full Year 2022 Earnings

Rhea-AI Summary

Stepan Company (NYSE: SCL) reported $10.8 million in net income for Q4 2022, down from $17.0 million a year earlier. Adjusted net income also fell to $13.5 million from $22.5 million. Total sales volume decreased by 17%, primarily due to reduced global commodity laundry demand and inventory destocking. Surfactant operating income dropped to $21.8 million, while Polymer operating income fell to $3.0 million. Conversely, Specialty Products saw an increase in operating income to $6.6 million. Despite challenges, the company achieved a record full-year net income of $147.2 million. The outlook for 2023 foresees potential headwinds from high inflation and interest rates affecting demand.

Positive

• Record full-year net income of $147.2 million, up 7% year-over-year.
• Specialty Product segment operating income increased to $6.6 million.
• Total net sales for the year rose 18% to $2.77 billion.

Negative

• Q4 net income down 36% to $10.8 million due to lower sales volumes.
• Surfactant operating income decreased by 33% due to declining demand.
• Guidance for 2023 suggests challenges from high inflation and interest rates.

NORTHBROOK, Ill., Feb. 16, 2023 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported:

Fourth Quarter Highlights

• Reported net income was $10.8 million, or $0.47 per diluted share, versus $17.0 million, or $0.73 per diluted share, in the prior year. Adjusted net income* was $13.5 million, or $0.59 per diluted share versus $22.5 million, or $0.97 per diluted share, in the prior year. Total Company sales volume decreased 17% versus the prior year.
• Surfactant operating income was $21.8 million versus $32.4 million in the prior year. This decrease was primarily due to a 15% decline in global sales volume that was partially offset by improved product and customer mix. The lower sales volume was mostly due to lower global commodity laundry demand, lower demand within the North American Personal Care end market and customer inventory destocking. Higher global demand in the Agricultural and Institutional Cleaning end markets partially offset the above.
• Polymer operating income was $3.0 million versus $12.9 million in the prior year. This decrease was primarily due to a 23% decline in global sales volume, including a 21% volume decline in Rigid Polyols and lower demand in the Specialty Polyols and Phthalic Anhydride businesses. The lower demand reflects customer inventory destocking, lower construction-related activities and general economic concerns.
• Specialty Product operating income was $6.6 million versus $2.1 million in the prior year. This increase was primarily attributable to improved margins and customer mix within the medium chain triglycerides (MCT) product line and order timing differences within the food and flavor business.
• The effect of foreign currency translation negatively impacted net income by $0.4 million, or $0.02 per diluted share, versus the prior year.

Full Year Highlights

• Reported net income for full year 2022 was a record $147.2 million, or $6.38 per diluted share, versus $137.8 million, or $5.92 per diluted share, in the prior year. Adjusted net income* was a record $153.5 million, or $6.65 per diluted share, versus $143.5 million, or $6.16 per diluted share, in the prior year. Total Company sales volume declined 7% versus the prior year driven by a 12% decline in the second half of 2022.
• The Surfactant segment delivered operating income of $162.7 million, down 2% versus the prior year. Surfactant global sales volume was down 6% primarily due to lower global commodity laundry demand, raw material constraints and customer inventory destocking efforts. Higher demand for products sold into the Functional Products and Institutional Cleaning end markets partially offset the above. The Polymer segment delivered $82.9 million of operating income, up 13% versus the prior year. Global Polymer sales volume declined 7% versus the prior year due to customer inventory destocking and lower construction-related activities, primarily in the second half of the year. Specialty Product operating income was $29.9 million versus $14.2 million in the prior year.
• The effect of foreign currency translation negatively impacted net income by $5.6 million, or $0.24 per diluted share, versus the prior year.

*

Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

"The Company delivered record full year earnings in 2022 despite significant inflation across many cost elements, supply chain challenges, a slow down in demand across most end use markets and customer destocking efforts during the second half of the year.  Both reported net income and adjusted net income were up 7% versus 2021," said Scott Behrens, President and Chief Executive Officer.  "For the fourth quarter, both Surfactant and Polymer operating income were significantly impacted by customer and channel inventory destocking.  We saw lower demand, particularly in construction-related markets, consumer commodity laundry and from our Tier 2/3 customers.  In addition, Surfactant results were negatively impacted by higher expenses associated with our transition to low 1,4 dioxane capabilities, while Polymer results were negatively impacted by higher planned maintenance activity in our North American Phthalic Anhydride plant.  These headwinds were partially offset by improved product and customer mix inclusive of double digit sales volume growth into the Agricultural end market.  Specialty Product results improved significantly due to margin improvement and customer mix."

Financial Summary

	Three Months Ended December 31												Twelve Months Ended  December 31
($ in thousands, except per share data)	2022				2021				% Change				2022				2021				% Change
Net Sales	$	627,176			$	610,027				3	%		$	2,773,270			$	2,345,966				18	%
Operating Income	$	11,691			$	19,997				(42)	%		$	207,336			$	170,781				21	%
Net Income Attributable to Stepan	$	10,834			$	16,995				(36)	%		$	147,153			$	137,804				7	%
Earnings per Diluted Share	$	0.47			$	0.73				(36)	%		$	6.38			$	5.92				8	%
Adjusted Net Income *	$	13,456			$	22,493				(40)	%		$	153,473			$	143,499				7	%
Adjusted Earnings per Diluted Share *	$	0.59			$	0.97				(39)	%		$	6.65			$	6.16				8	%

* See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

 

Summary of Fourth Quarter Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

• Deferred Compensation: The 2022 fourth quarter reported net income includes $2.0 million of after-tax expense versus $2.2 million of after-tax expense in the prior year.
• Cash-Settled SARs: These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time. Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income. Reported net income in both the 2022 and 2021 fourth quarters include $0.2 million of after-tax expense.
• Business Restructuring and Asset Disposition: The 2022 fourth quarter reported net income includes $0.1 million of after-tax decommissioning expense related to the Company's Canadian plant closure. The fourth quarter of 2021 includes a $2.0 million after-tax loss on the sale of one of the Company's corporate headquarters buildings and $0.3 million of after-tax decommissioning expense related to the Company's Canadian plant closure.
• Environmental Remediation – The fourth quarter of 2022 reported net income includes $0.4 million of after-tax expense versus $0.8 million of after-tax expense in the prior year.

Percentage Change in Net Sales

Net sales in the fourth quarter of 2022 increased 3% year-over-year primarily due to higher selling prices that were mainly attributable to the pass-through of higher raw material and input costs as well as improved product and customer mix.  These higher selling prices were largely offset by a 17% decrease in global sales volume and the unfavorable impact of foreign currency translation.    

		Three Months Ended December 31, 2022				Twelve Months Ended December 31, 2022
Volume			(17)	%			(7)	%
Selling Price & Mix			24	%			30	%
Foreign Translation			(4)	%			(5)	%
Total			3	%			18	%

 

Segment Results

		Three Months Ended December 31												Twelve Months Ended  December 31
($ in thousands)		2022				2021				% Change				2022				2021				% Change
Net Sales
Surfactants		$	454,534			$	420,123				8	%		$	1,882,745			$	1,562,795				20	%
Polymers		$	148,309			$	173,676				(15)	%		$	789,080			$	713,440				11	%
Specialty Products		$	24,333			$	16,228				50	%		$	101,445			$	69,731				45	%
Total Net Sales		$	627,176			$	610,027				3	%		$	2,773,270			$	2,345,966				18	%
		Three Months Ended December 31												Twelve Months Ended  December 31
($ in thousands, all amounts pre-tax)		2022				2021				% Change				2022				2021				% Change
Operating Income
Surfactants		$	21,752			$	32,441				(33)	%		$	162,746			$	165,999				(2)	%
Polymers		$	2,992			$	12,862				(77)	%		$	82,897			$	73,591				13	%
Specialty Products		$	6,649			$	2,126				213	%		$	29,895			$	14,178				111	%
Segment Operating Income		$	31,393			$	47,429				(34)	%		$	275,538			$	253,768				9	%
Corporate Expenses		$	(19,702)			$	(27,432)				(28)	%		$	(68,202)			$	(82,987)				(18)	%
Consolidated Operating Income		$	11,691			$	19,997				(42)	%		$	207,336			$	170,781				21	%

 

Total segment operating income for the fourth quarter of 2022 decreased $16.0 million, or 34%, versus the prior year quarter.  Total segment operating income for full year 2022 increased $21.8 million, or 9%, versus the prior year.   

• Surfactant net sales were $454.5 million for the quarter, an 8% increase versus the prior year. Selling prices were up 26% primarily due to the pass-through of higher raw material and input costs as well as improved product and customer mix. Sales volume decreased 15% year-over-year primarily due to lower global commodity laundry demand, lower demand within the North American Personal Care end market and customer inventory destocking. Higher global demand for products sold into the Agricultural and Institutional Cleaning end markets partially offset the above. The unfavorable impact of foreign currency translation negatively impacted net sales by 3%. Surfactant operating income for the quarter decreased $10.7 million versus the prior year primarily due to the 15% decline in sales volume and higher expenses associated with the Company's transition to low 1,4 dioxane capabilities.
• Polymer net sales were $148.3 million for the quarter, a 15% decrease versus the prior year. Selling prices increased 14% primarily due to the pass through of higher raw material and input costs. Sales volume decreased 23% in the quarter primarily due to a 21% decline in Rigid Polyols and lower demand in the Specialty Polyols and Phthalic Anhydride businesses. The lower demand reflects customer inventory destocking, lower construction-related activities and general economic concerns. The translation impact of a stronger U.S. dollar negatively impacted net sales by 6%. Polymer operating income decreased $9.9 million versus the prior year primarily due to the 23% decrease in global sales volume and higher costs associated with planned maintenance activity at the Company's North American Phthalic Anhydride plant
• Specialty Product net sales were $24.3 million for the quarter, a 50% increase versus the prior year. Sales volume was down 6% between years while operating income increased $4.5 million. The operating income increase was primarily attributable to improved margins and customer mix within the MCT product line and order timing differences within our food and flavor business.

Corporate Expenses

		Three Months Ended December 31												Twelve Months Ended  December 31
($ in thousands)		2022				2021				% Change				2022				2021				% Change
Total  -  Corporate Expenses		$	19,702			$	27,432				(28)	%		$	68,202			$	82,987				(18)	%
Less:
Deferred Compensation Expense		$	3,645			$	4,747				(23)	%		$	(9,393)			$	6,895				(236)	%
Business Restructuring and Asset Disposition		$	83			$	3,086				(97)	%		$	308			$	3,353				(91)	%
Environmental Remediation Expense		$	481			$	1,031				(53)	%		$	11,483			$	1,977				481	%
Adjusted Corporate Expense		$	15,493			$	18,568				(17)	%		$	65,804			$	70,762				(7)	%

* See Table III for a discussion of deferred compensation plan accounting.

 

• Corporate expenses, excluding deferred compensation, business restructuring and environmental costs, decreased $3.1 million, or 17% for the quarter.  The decrease was primarily due to lower incentive-based compensation expenses, lower consulting expenses and the favorable impact of foreign currency translation.      

Income Taxes

The Company's full year effective tax rate was 22.0% in 2022 versus 20.1% in 2021.  This year-over-year increase was primarily due to non-recurring favorable tax benefits recognized in 2021.        

Shareholder Return

The Company paid $8.1 million of dividends to shareholders and repurchased $2.7 million of Company stock in the fourth quarter of 2022.  For the full year the Company paid $30.6 million of dividends and repurchased $24.9 million of Company stock.  The Company has $125.1 million remaining under the share repurchase program authorized by its Board of Directors.  With the cash dividend increase in the fourth quarter of 2022, the Company has increased its dividend on the Company's common stock for the 55th consecutive year.

Selected Balance Sheet Information

The Company's total debt increased by $22.2 million and cash increased by $8.1 million versus September 30, 2022.  The increase in debt primarily reflects borrowings against the Company's revolving credit facility that were partially offset by scheduled debt repayments.  The Company's net debt level increased $14.1 million versus September 30, 2022 and the net debt ratio remained constant at 26% (Net Debt and Net Debt Ratios are non-GAAP measures).

($ in millions)	12/31/22				9/30/22				6/30/22				3/31/22				12/31/21
Net Debt
Total Debt	$	587.1			$	564.9			$	526.0			$	537.1			$	363.6
Cash		173.8				165.7				194.6				236.0				159.2
Net Debt	$	413.3			$	399.2			$	331.4			$	301.1			$	204.4
Equity		1,166.1				1,130.2				1,125.7				1,116.7				1,074.2
Net Debt + Equity	$	1,579.4			$	1,529.4			$	1,457.1			$	1,417.8			$	1,278.6
Net Debt / (Net Debt + Equity)		26	%			26	%			23	%			21	%			16	%

 

The major working capital components were:

($ in millions)	12/31/22				9/30/22				6/30/22				3/31/22				12/31/21
Net Receivables	$	436.9			$	476.2			$	518.8			$	504.5			$	419.5
Inventories		402.5				397.6				340.7				308.4				305.5
Accounts Payable		(375.7)				(350.1)				(366.2)				(350.8)				(323.4)
	$	463.7			$	523.7			$	493.3			$	462.1			$	401.6

 

The Company had full year capital expenditures of $301.6 million in 2022 versus $194.5 million in the prior year.  The year-over-year increase is primarily due to increased expenditures in the U.S. for the advancement of the Company's new alkoxylation facility in Pasadena, Texas, which is expected to provide flexible capacity of 75,000 metric tons per year, and new capability and capacity to produce ether sulfates that meet new regulatory limits on 1,4 dioxane.

2023 Outlook

"The Company delivered record income in 2022 and I want to thank all our employees for their excellent work.  We have now delivered three consecutive years of record earnings," said Scott Behrens, President and Chief Executive Officer.  "Looking forward, we believe 2023 will be challenged by continued elevated inflation and high interest rates.  We believe this macro environment could negatively impact consumer demand and construction-related activity which will affect both our Surfactant and Polymer businesses.  Additionally, we believe higher overall cost inflation, higher depreciation and pre-start up expenses associated with our new Pasadena site, will challenge our ability to deliver earnings growth in 2023.  We are seeking to partially offset these 2023 headwinds with productivity improvements, pricing increases where possible, and furthering our efforts to improve product and customer mix.  Despite this projected macro environment, we remain committed to executing our long-term growth strategy."  

Conference Call

Stepan Company will host a conference call to discuss its fourth quarter and full year 2022 results at 10:00 a.m. ET (9:00 a.m. CT) on February 16, 2023. The call can be accessed by phone and webcast.  To access the call by phone, please click on this Registration Link,  complete the form and you will be provided with dial in details and a PIN.  To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time.  The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

Supporting Slides

Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com

Contact: Luis E. Rojo 847-446-7500

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

Table I
STEPAN COMPANY For the Three and Twelve Months Ended December 31, 2022 and 2021 (Unaudited – in thousands, except per share data)
		Three Months Ended December 31								Twelve Months Ended December 31
		2022				2021				2022				2021
Net Sales		$	627,176			$	610,027			$	2,773,270			$	2,345,966
Cost of Sales			559,416				526,774				2,346,201				1,950,156
Gross Profit			67,760				83,253				427,069				395,810
Operating Expenses:
Selling			13,122				14,906				59,030				59,186
Administrative			22,678				23,466				102,177				92,906
Research, Development and Technical Services			16,541				17,051				66,633				62,689
Deferred Compensation Expense			3,645				4,747				(9,393)				6,895
			55,986				60,170				218,447				221,676
Goodwill Impairment			-				-				978				-
Business Restructuring and Asset Disposition			83				3,086				308				3,353
Operating Income			11,691				19,997				207,336				170,781
Other Income (Expense):
Interest, Net			(2,555)				(1,063)				(9,809)				(5,753)
Other, Net			175				3,303				(8,824)				7,509
			(2,380)				2,240				(18,633)				1,756
Income Before Income Taxes			9,311				22,237				188,703				172,537
Provision for Income Taxes			(1,523)				5,179				41,550				34,642
Net Income			10,834				17,058				147,153				137,895
Net (Income) Attributable to Noncontrolling Interests			-				(63)				-				(91)
Net Income Attributable to Stepan Company		$	10,834			$	16,995			$	147,153			$	137,804
Net Income Per Common Share Attributable to Stepan Company
Basic		$	0.48			$	0.74			$	6.46			$	6.01
Diluted		$	0.47			$	0.73			$	6.38			$	5.92
Shares Used to Compute Net Income Per Common Share Attributable to Stepan Company
Basic			22,685				22,868				22,781				22,922
Diluted			22,994				23,254				23,064				23,287

 

Table II
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share *
		Three Months Ended December 31																Twelve Months Ended December 31
($ in thousands, except per share amounts)		2022				EPS				2021				EPS				2022				EPS				2021				EPS
Net Income Reported		$	10,834			$	0.47			$	16,995			$	0.73			$	147,153			$	6.38			$	137,804			$	5.92
Deferred Compensation (Income) Expense		$	2,000			$	0.09			$	2,168			$	0.09			$	(2,369)			$	(0.10)			$	1,484			$	0.06
Business Restructuring/Asset Disposition Exp.		$	62			$	0.00			$	2,343			$	0.10			$	231			$	0.01			$	2,543			$	0.11
Cash-Settled SARs (Income) Expense		$	194			$	0.01			$	203			$	0.01			$	(270)			$	(0.01)			$	165			$	0.01
Environmental Remediation Expense		$	366			$	0.02			$	784			$	0.04			$	8,728			$	0.37			$	1,503			$	0.06
Adjusted Net Income		$	13,456			$	0.59			$	22,493			$	0.97			$	153,473			$	6.65			$	143,499			$	6.16

*	All amounts in this table are presented after-tax

 

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

Reconciliation of Pre-Tax to After-Tax Adjustments
		Three Months Ended December 31																Twelve Months Ended December 31
($ in thousands, except per share amounts)		2022				EPS				2021				EPS				2022				EPS				2021				EPS
Pre-Tax Adjustments
Deferred Compensation (Income) Expense		$	2,631							$	2,853							$	(3,117)							$	1,952
Business Restructuring/Asset Disposition Exp.		$	83							$	3,086							$	308							$	3,353
Cash-Settled SARs (Income) Expense		$	255							$	267							$	(354)							$	217
Environmental Remediation Expense		$	481							$	1,031							$	11,483							$	1,977
Total Pre-Tax Adjustments		$	3,450							$	7,237							$	8,320							$	7,499
Cumulative Tax Effect on Adjustments		$	(828)							$	(1,739)							$	(2,000)							$	(1,804)
After-Tax Adjustments		$	2,622			$	0.12			$	5,498			$	0.24			$	6,320			$	0.27			$	5,695			$	0.24

 

Table III
Deferred Compensation Plans
The full effect of the deferred compensation plans on quarterly pre-tax income was $2.6 million of expense versus $2.9 million of expense in the prior year.  The year-to-date impact was $3.1 million of pre-tax income versus $2.0 million of pre-tax expense in the prior year.  The accounting for the deferred compensation plans results in operating income when the price of Stepan Company common stock or mutual funds held in the plans fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Company common stock were as follows:
		2022																2021
		12/31				9/30				6/30				3/31				12/31				9/30				6/30				3/31
Stepan Company		$	106.46			$	93.67			$	101.35			$	98.81			$	124.29			$	112.94			$	120.27			$	127.11

 

The deferred compensation income statement impact is summarized below:

		Three Months Ended December 31								Twelve Months Ended December 31
($ in thousands)		2022				2021				2022				2021
Deferred Compensation
Operating Income (Expense)		$	(3,645)			$	(4,747)			$	9,393			$	(6,895)
Other, net – Mutual Fund Gain (Loss)			1,014				1,894				(6,276)				4,943
Total Pretax		$	(2,631)			$	(2,853)			$	3,117			$	(1,952)
Total After Tax		$	(2,000)			$	(2,168)			$	2,369			$	(1,484)

 

Table IV
Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign currency exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income statement line items for the three and twelve month periods ending December 31, 2022 as compared to 2021:
($ in millions)		Three Months Ended December 31								Increase (Decrease)				Change Due to Foreign Currency Translation				Twelve Months Ended December 31								Increase (Decrease)				Change Due to Foreign Currency Translation
		2022				2021												2022				2021
Net Sales		$	627.2			$	610.0			$	17.2			$	(22.5)			$	2,773.3			$	2,346.0			$	427.3			$	(95.4)
Gross Profit			67.8				83.3				(15.5)				(1.4)				427.1				395.8				31.3				(11.1)
Operating Income			11.7				20.0				(8.3)				(0.7)				207.3				170.8				36.5				(7.4)
Pretax Income			9.3				22.2				(12.9)				(0.4)				188.7				172.5				16.2				(7.2)

 

Table V
Stepan Company Consolidated Balance Sheets December 31, 2022 and December 31, 2021
		December 31, 2022				December 31, 2021
ASSETS
Current Assets		$	1,044,802			$	913,368
Property, Plant & Equipment, Net			1,073,297				850,604
Other Assets			315,073				301,640
Total Assets		$	2,433,172			$	2,065,612
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities		$	670,649			$	500,476
Deferred Income Taxes			10,179				12,491
Long-term Debt			455,029				322,862
Other Non-current Liabilities			131,250				155,590
Total Stepan Company Stockholders' Equity			1,166,065				1,074,193
Noncontrolling Interest			-				-
Total Liabilities and Stockholders' Equity		$	2,433,172			$	2,065,612

 

View original content:https://www.prnewswire.com/news-releases/stepan-reports-fourth-quarter-results-and-record-full-year-2022-earnings-301748508.html

SOURCE Stepan Company

FAQ

What were Stepan Company's earnings results for Q4 2022?

Stepan Company reported a net income of $10.8 million or $0.47 per diluted share in Q4 2022, down from $17.0 million or $0.73 per diluted share in the same quarter last year.

How did Stepan Company's sales volume change in 2022?

Total sales volume for Stepan Company decreased by 17% in Q4 2022 and 7% for the full year compared to the prior year.

What is Stepan Company's outlook for 2023?

Stepan Company anticipates challenges in 2023 due to high inflation and interest rates, which could negatively impact consumer demand and construction-related activities.

How much did Stepan Company increase its dividend in 2022?

Stepan Company increased its dividend for the 55th consecutive year, paying $30.6 million in dividends for the full year 2022.

What was the adjusted net income for Stepan Company in Q4 2022?

The adjusted net income for Q4 2022 was $13.5 million, a decrease from $22.5 million in Q4 2021.